Nirsevimab Immunisation Significantly Reduces Respiratory Syncytial Virus‐Associated Bronchiolitis Hospitalisations and Alters Seasonal Patterns
Nirsevimab immunisation significantly reduced RSV-associated bronchiolitis admissions, though an increase in rhinovirus- and metapneumovirus-associated cases was observed.
Authors
- Enrique Palomo Atance (ORCID: https://orcid.org/0000-0003-4671-5215)
- Juan Manuel Rius‐Peris (ORCID: https://orcid.org/0000-0001-6779-4982)
- Raúl Alcaraz (ORCID: https://orcid.org/0000-0002-0942-3638)
- Laura Murcia‐Clemente
- Eva Muro‐Díaz
- Cristina Llorente‐Ruiz
Institutions
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Virgen de la Luz (ES)
- Hospital Universitario de Guadalajara (ES)
- Hospital General Universitario de Ciudad Real (ES)
- Hospital Universitario del Vinalopó (ES)
- University of Castilla-La Mancha (ES)
Publication Details
- Journal
- Acta Paediatrica
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1111/apa.70066
- Citations
- 15
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 20.31